The Trump administration expanded its government stock portfolio to include 30 companies, adding 6 chipmakers as part of a broader effort to secure domestic semiconductor supply. The move follows earlier CHIPS Act funding and reflects policy focus on reducing reliance on Taiwan and South Korea for advanced manufacturing.
Trump Administration Adds 6 Chipmakers to U.S. Portfolio
Government stock purchases signal long-term commitment to domestic semiconductor supply chain.

| Ticker | Company | 1-year change |
|---|---|---|
| INTC | Intel | +249.2% |
| MU | Micron | +468.4% |
Government stock purchases of chipmakers signal they are now strategic assets—a long-term bet on domestic supply.
The chipmakers added to the portfolio are the direct winners, gaining implicit government endorsement and signaling stable, long-term demand from federal procurement. Companies like Intel INTC, Micron MU, and potentially smaller foundries or specialty chip makers benefit from visibility that they are strategic assets. Government portfolio ownership also reduces political risk around tariffs or export controls—these companies are now embedded in U.S. national security strategy. Investors may interpret the move as a floor under valuations and a hedge against geopolitical disruption.
Foreign chipmakers and Taiwan-dependent supply chains face indirect pressure. The portfolio expansion reinforces the administration's "America First" semiconductor policy, which favors domestic production over imports. Companies reliant on TSMC or Samsung for advanced nodes face longer-term margin pressure as U.S. customers shift to domestic alternatives, even at higher cost.
Watch for the specific list of 6 chipmakers added and their stock reactions. If the portfolio includes mid-cap players like ON Semiconductor (ON) or Skyworks Solutions (SWKS), those names gain outsized credibility. Monitor federal procurement announcements and CHIPS Act funding awards to confirm the portfolio is backed by actual contract flow.
Source: original report ↗
Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/moJoin the owners who run ahead of the industry. Cancel anytime, one click.